Techniques in Vascular & Interventional Radiology
Volume 9, Issue 2 , Pages 69-76 , June 2006

Antibiotic Prophylaxis in Interventional Radiology—Anything New?

  • P. Beddy, MD, MRCS
  • ,
  • J.M. Ryan, MD, FRCR, FFRRCSI

      Affiliations

    • Corresponding Author InformationAddress reprint requests to J. Mark Ryan, Department of Interventional Radiology, St. James Hospital, Dublin 8, Ireland.

References 

  1. Spies JB, Rosen RJ, Lebovitz AS. Antibiotic prophylaxis in vascular and interventional radiology: a rational approach. Radiology. 1988;166:381–387
  2. Ryan JM, Ryan BM, Smith TP. Antibiotic prophylaxis in interventional radiology. J Vasc Interv Radiol. 2004;15:547–556
  3. McDermott VG, Schuster MG, Smith TP. Antibiotic prophylaxis in vascular and interventional radiology. AJR Am J Roentgenol. 1997;169:31–38
  4. Dravid VS, Gupta A, Zegel HG, et al. Investigation of antibiotic prophylaxis usage for vascular and nonvascular interventional procedures. J Vasc Interv Radiol. 1998;9:401–406
  5. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis. 2003;36:1284–1289
  6. Wenzel PR. Preoperative antibiotic prophylaxis. N Engl J Med. 1992;326:337–339
  7. Miles AA, Miles EM, Burke J. The value and duration of defense reactions of the skin to primary lodgment of bacteria. Br J Exp Pathol. 1957;38:79–96
  8. Leone M, Albanese J, Tod M, et al. Ceftriaxone (1 g intravenously) penetration into abdominal tissues when administered as antibiotic prophylaxis during nephrectomy. J Chemother. 2003;15:139–142
  9. Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery. 1961;50:161–168
  10. Stone HH, Hooper CA, Kolb LD, et al. Antibiotic prophylaxis in gastric, biliary, and colonic surgery. Ann Surg. 1976;184:443–452
  11. Strachan CJ. Prophylactic use of cefazolin against sepsis after cholecystectomy. BMJ. 1977;1:1254–1256
  12. Classen DC, Evans RS, Pestotnik SL. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med. 1992;326:281–286
  13. DiPiro JT, Cheung RP, Bowden TA, et al. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg. 1986;152:552–559
  14. Thadepalli H, Mandal AK. Antibiotic prophylaxis in the surgical patient. Infez Med. 1998;6:71–80
  15. National nosocomial infections surveillance (NNIS) system report (Data summary from January 1992-April 2000). Am J Infect Control. 2000;28:429–448
  16. Dzidic S, Bedekovic V. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria. Acta Pharmacol Sin. 2003;24:519–526
  17. Macpherson RD, Willcox C, Chow C, et al. Anaesthetist’s response to patients’ self-reported drug allergies. Br J Anaesth. 2006;97(5):634–639Epub 2006
  18. Cunha BA. Antimicrobial selection in the penicillin-allergic patient. Drugs Today. 2001;37:377–383
  19. Borsch JE, Anderson KE, Bindsley-Jensen C. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Basic Clin Pharmacol Toxicol. 2006;98:357–362
  20. Shawker TH, Kluge RM, Ayella RJ. Bacteremia associated with angiography. JAMA. 1974;229:1180–1182
  21. Meyer P, Reizine D, Aymard A, et al. Septic complications in interventional radiology: evaluation of risk and preventive measures (Preliminary studies). J Intervent Radiol. 1988;3:73–75
  22. Fiorani P, Speziale F, Calisti A, et al. Endovascular graft infection: preliminary results of an international enquiry. J Endovasc Ther. 2003;10(5):919–927
  23. Dieter RS. Coronary artery stent infection. Clin Cardiol. 2000;23:808–810
  24. Deitch JS, Hansen KJ, Regan JD, et al. Infected renal artery pseudoaneurysm and mycotic aortic aneurysm after percutaneous transluminal renal artery angioplasty and stent placement in a patient with a solitary kidney. J Vasc Surg. 1998;28:340–344
  25. Deiparine MK, Ballard JL, Taylor FC, et al. Endovascular stent infection. J Vasc Surg. 1996;23:529–533
  26. Bunt TJ, Gill HK, Smith DC, et al. Infection of a chronically implanted iliac artery stent. Ann Vasc Surg. 1997;11:529–532
  27. Kaviani A, Ouriel K, Kashyap VS. Infected carotid pseudoaneurysm and carotid-cutaneous fistula as a late complication of carotid artery stenting. J Vasc Surg. 2006;43(2):379–382
  28. Walton KB, Hudenko K, D’Ayala M, et al. Aneurysmal degeneration of the superficial femoral artery following stenting: an uncommon infectious complication. Ann Vasc Surg. 2003;17(4):445–448
  29. McCready RA, Siderys H, Pittman JN, et al. Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. J Vasc Surg. 1991;14:170–174
  30. Malek AM, Higashida RT, Reilly LM, et al. Subclavian arteritis and pseudoaneurysm formation secondary to stent infection. Cardiovasc Intervent Radiol. 2000;23:57–60
  31. Becker GJ, Kovacs M, Mathison MN, et al. Risk stratification and outcomes of transluminal endografting for abdominal aortic aneurysm: 7-year experience and long-term follow-up. J Vasc Interv Radiol. 2001;12:1033–1046
  32. Whitton Hollis H, Rehring TF. Femoral endarteritis associated with percutaneous suture closure: new technology, challenging complications. J Vasc Surg. 2003;38(1):83–87
  33. Sohail MR, Khan AH, Holmes DR, et al. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc. 2005;80(8):1011–1015
  34. Carey D, Martin JR, Moore CA, et al. Complications of femoral artery closure devices. Catheter Cardiovasc Interv. 2001;52:3–7
  35. Nikolsky E, Mehren R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 15. 2004;44(6):1200–1209
  36. Openshaw KL, Picus D, Hicks ME, et al. Interventional radiologic placement of Hohn central venous catheters: results and complications in 100 consecutive patients. J Vasc Interv Radiol. 1994;5:111–115
  37. Richet H, Hubert B, Nitemberg G, et al. A prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol. 1990;28(11):2520–2525
  38. Cicalini S, Palmieri F, Petrosillo N. Clinical review: new technologies for prevention of intravascular catheter-related infections. Crit Care. 2004;8(3):157–162
  39. Mermel LA. New technologies to prevent intravascular catheter related bloodstream infections. Emerg Infect Dis. 2001;7:197–199
  40. Raad I, Darouiche R, Dupuis J, et al. The Texas Medical Center Catheter Study Group Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections (A randomized, double-blind trial). Ann Intern Med. 1997;127(4):267–274
  41. Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281(3):261–267
  42. Bassetti S, Hu J, D’Agostino RB, et al. Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother. 2001;45(5):1535–1538
  43. Raad II, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med. 2002;162(8):871–878
  44. Van de Wetering DE, Van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev. 2003;(2):CD003295
  45. Van de Wetering, van Woensel JB, Kremer LCM, et al. Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review. Cancer Treat Rev. 2005;31(3):186–196
  46. Lin M, Soo TB, Horn LC. Successful retrieval of infected Gunther Tulip IVC filter. J Vasc Interv Radiol. 2000;11(10):1341–1343
  47. Kinney TB. Update on inferior vena cava filters. J Vasc Interv Radiol. 2003;14(4):425–440
  48. Dovrish Z, Hadary R, Blickstein D, et al. Retrospective analysis of the use of inferior vena cava filters in routine hospital practice. Postgrad Med J. 2006;82(964):150–153
  49. Miyahara T, Miyata T, Shigematsu K, et al. Clinical outcome and complications of temporary inferior vena cava filter placement. J Vasc Surg. 2006;44(3):620–624
  50. Yee AC, Ho C-S. Complications of percutaneous drainage: benign versus malignant diseases. AJR Am J Roentgenol. 1987;148:1207–1209
  51. Condon RE, Wittmann DH. The use of antibiotics in general surgery. In:  Wills SA editors. Current Problems in Surgery. Chicago, IL: Mosby Year Book; 1991;
  52. Hamlin JA, Friedman M, Stein MG, et al. Percutaneous biliary drainage: complications of 118 consecutive catheterizations. Radiology. 1986;158:199–202
  53. Funaki B, Zaleski GX, Straus CA, et al. Percutaneous biliary drainage in patients with nondilated intrahepatic ducts. AJR Am J Roentgenol. 1999;173:1541–1544
  54. Brody LA, Brown KT, Getrajdman GI, et al. Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage. J Vasc Interv Radiol. 1998;9:572–578
  55. Thompson BF, Arguedas MR, Wilcox CM. Antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice: is it worth the cost?. Aliment Pharmacol Ther. 2002;16:727–734
  56. Chen C, Chen PJ, Yang PM. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol. 1997;92:2257–2259
  57. de Baere T, Roche A, Amenabar JA, et al. Liver abscess formation after local treatment of liver tumors. Hepatology. 1996;23:1436–1440
  58. Kim W, Clark TW, Baum RA, et al. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12:965–968
  59. Geschwind JF, Kaushik S, Ramsey DE, et al. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol. 2002;13:1163–1166
  60. Chen C, Chen PJ, Yang PM, et al. Clinical features and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol. 1997;92:2257–2259
  61. Song SY, Chung JW, Han JK, et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol. 2001;12:313–320
  62. Gauderer MW, Ponsky JL, Izabt RJ. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg. 1980;15(6):872–875
  63. Preshaw RM. A percutaneous method for inserting a feeding gastrostomy tube. Surg Gynecol Obstet. 1981;152(5):658–660
  64. Giuliano AW, Yoon HC, Lomis NM, et al. Fluoroscopically guided percutaneous placement of large-bore gastrostomy and gastrojejunostomy tubes: review of 109 cases. J Vasc Interv Radiol. 2000;11(2 Pt. 1):239–246
  65. Ravina JH. Arterial embolisation to treat uterine myomata. Lancet. 1995;346(8976):671–672
  66. Pron G, Mocarski E, Cohen M, et al. Hysterectomy for complications after uterine artery embolization for leiomyoma: results of a Canadian multicenter clinical trial. J Am Assoc Gynecol Laparosc. 2003;10:99–106
  67. Walker WJ, Pelage JP. Uterine artery embolization in symptomatic fibroids: clinical results in 400 women with imaging follow up. Br J Obstet Gynaecol. 2002;109:1262–1272
  68. SOGC clinical practice guidelines (Uterine fibroid embolization (UFE)). 2004;Number 150, October
  69. de Blok S, De Vries C, Prinssen H, et al. Fatal sepsis after uterine artery embolization with microspheres. J Vasc Interv Radiol. 2003;14(6):779–783
  70. Pelage JP, Jacob D, Le Dref O, et al. Fatal sepsis after uterine artery embolization with microspheres. J Vasc Interv Radiol. 2004;15(4):405–406
  71. Walker WJ, Pelage JP, Sutton C. Fibroid embolisation. Clin Radiol. 2002;57:325–331
  72. Ryan JM, Gainey M, Glasson J, et al. Simplified pain protocol after uterine artery embolization. Radiology. 2002;224:610–612
  73. Siskin GP, Stainken BF, Dowling K, et al. Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients. J Vasc Interv Radiol. 2000;11:305–311
  74. Katsumori T, Nakajima K, Mihara T, et al. Uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids. AJR Am J Roentgenol. 2002;178:135–139
  75. Walker W, Green A, Sutton C. Bilateral uterine artery embolization for myomata: results, complications and failures. Min Invas Ther Allied Technol. 1999;8:449–454
  76. Pron G, Bennett J, Common A, et al. The Ontario UFE Collaborative Group Technical results and effects of operator experience on uterine artery embolization for fibroids: The Ontario Uterine Fibroid Embolization Trial. J Vasc Interv Radiol. 2003;14:545–554
  77. Rajan DK, Beecroft JR, Clark TW, et al. Risk of intrauterine infectious complications after uterine artery embolization. J Vasc Interv Radiol. 2004;15(12):1415–1421
  78. Vashisht A, Studd J, Carey A, et al. Fatal septicemia after fibroid embolization. Lancet. 1999;354:307–308
  79. Saxon RR. A new era for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 2004;15:217–219
  80. Deibert P, Schwarz S, Olschewski M, et al. Risk factors and prevention of early infection after implantation or revision of transjugular intrahepatic portosystemic shunts: results of a randomized study. Dig Dis Sci. 1998;43:1708–1713
  81. Freedman AM, Sanyal AJ, Tisnado J, et al. Complications of transjugular intrahepatic portosystemic shunts: a comprehensive review. Radiographics. 1993;13:1185–1210
  82. Sanyal AJ, Reddy KR. Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology. 1998;115:110–115
  83. Schiano TD, Atillasoy E, Fiel MI, et al. Fatal fungaemia resulting from an infected transjugular intrahepatic portosystemic shunt stent. Am J Gastroenterol. 1997;92:709–710
  84. DeSimone JA, Beavis KG, Eschelman DJ, et al. Sustained bacteremia associated with transjugular intrahepatic portosystemic shunt (TIPS). Clin Infect Dis. 2000;30:384–386
  85. Armstrong PK, MacLeod C. Infection of transjugular intrahepatic portosystemic shunt devices: three cases and a review of the literature. Clin Infect Dis. 2003;36:407–412
  86. Shibata T, Yamamoto Y, Yamamoto N, et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol. 2003;14(12):1535–1542
  87. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities—part II. J Vasc Interv Radiol. 2001;12:1135–1148
  88. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441–451
  89. Rhim H, Dodd GD, Chintapalli KN, et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics. 2004;24(1):41–52
  90. Alfanso OM, Gonzalez SA, Clemente DJ, et al. Infected vertebroplasty due to uncommon bacteria solved surgically: a rare and threatening life complication of a common procedure: report of a case and a review of the literature. Spine. 2006;31(20):E770–E773
  91. Walker DH, Mummaneni P, Rodts GE. Infected vertebroplasty (Report of two cases and review of the literature). Neurosurg Focus. 2004;17(6):E6
  92. Mathis JM, Wong W. Percutaneous vertebroplasty: technical consideration. J Vasc Interv Radiol. 2003;14:953–960
  93. Goodwin WE, Casey WC, Wolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis. JAMA. 1955;157:891–894
  94. Gray RR, So CB, McLoughlin RF, et al. Outpatient percutaneous nephrostomy. Radiology. 1996;198:85–88
  95. Cochran ST, Barbaric ZL, Lee JJ, et al. Nephrostomy tube placement: an outpatient procedure?. Radiology. 1991;179:843–847
  96. Millward SF. Percutaneous nephrostomy: a practical approach. J Vasc Interv Radiol. 2000;11:955–964
  97. Beddy P, Geoghegan T, Browne RF, et al. Testicular varicoceles. Clin Radiol. 2005;60(12):1248–1255
  98. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Guideline for Prevention of Surgical Site Infection, 1999. Am J Infect Control. 1999;27:97–132

PII: S1089-2516(06)00049-7

doi: 10.1053/j.tvir.2006.12.005

Techniques in Vascular & Interventional Radiology
Volume 9, Issue 2 , Pages 69-76 , June 2006